Turner Investments’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Turner Investments’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-62,210	Closed	-$958K	–	281
2016 Q4	$958K	Sell	62,210 -14,550	-19%	-$189K	0.39%	97
2016 Q3	$999K	Buy	76,760 +13,280	+21%	+$176K	0.33%	102
2016 Q2	$883K	Buy	+63,480	New	+$935K	0.28%	105
2016 Q1	–	Sell	-61,430	Closed	-$1.17M	–	272
2015 Q4	$1.17M	Buy	61,430 +8,710	+17%	+$166K	0.24%	124
2015 Q3	$1M	Buy	+52,720	New	+$1.31M	0.2%	147

Other funds holding PRTK

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Turner Investments's PRTK Position: Q1 2017 in Review

Turner Investments sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q1 2017, closing a stake of 62,210 shares — an estimated $958K sold.

Turner Investments first reported a position in PRTK in Q3 2015 and held it in 5 quarters. The position peaked at $1.17M in Q4 2015. 103 funds tracked by Wall St. Rank hold PRTK as of Q1 2017.

Turner Investments reported no remaining Paratek Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Turner Investments sold 62,210 Paratek Pharmaceuticals, Inc. shares in Q1 2017, an estimated $958K.
Turner Investments first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2015 and held it in 5 quarters.
Turner Investments's Paratek Pharmaceuticals, Inc. position peaked at $1.17M in Q4 2015.
103 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.